UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-KSB

[X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
    OF 1934

                  For the Fiscal Year Ended: 29 February, 2004

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
    OF 1934

              For the transition period from _________ to _________

                          COMMISSION FILE NO. 333-86706

                           CROWN MEDICAL SYSTEMS, INC.
              Exact Name of Registrant as Specified in its Charter)

<TABLE>
<CAPTION>
            NEVADA                           7374                     98-0375957
            ------                           -----                    ----------
<S>                              <C>                              <C>
(State or Other Jurisdiction of  (Primary Standard Industrial        (IRS Employer
       Incorporation)             Classification Code Number)     Identification. No.)
</TABLE>

                  6006 N. MESA, SUITE 709, EL PASO, TEXAS 79912
               ---------------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)

         Issuer's telephone number, including area code: (915) 845-1787

    Securities registered pursuant to Section 12(b) of the Exchange Act: None

  Securities registered pursuant to Section 12(g) of the Act: Common Stock, par
                             value $0.001 per share


Check  whether the Issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Securities  Exchange  Act  during the past 12 months (or for
such shorter period that the registrant was required to file such reports),  and
(2) has been subject to such filing requirements for the past 90 days.

              Yes  _X_                               No _____


Check if there is no disclosure of delinquent  filers in response to Item 405 of
Regulation  S-B is not  contained  in  this  form,  and no  disclosure  will  be
contained,   to  the  best  of  registrant's   knowledge,  in  definitive  proxy
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB.

              Yes  _X_                               No _____


State issuer's revenues for its most recent fiscal year:     Nil


                                        1
<PAGE>


State the aggregate market value of the voting and non-voting common equity held
by non-affiliates  computed by reference to the price at which the common equity
was sold,  or the average bid and asked  price of such  common  equity,  as of a
specified  date within the past 60 days.  (See  definition  of affiliate in Rule
12b-2 of the Exchange Act.)

$14,112,000 as at June 9, 2004 based on the last sale price of our shares

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date.

20,451,835


TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                                                  Page
<S>        <C>                                                                                     <C>
ITEM 1:    DESCRIPTION OF BUSINESS                                                                  3
ITEM 2:    DESCRIPTION OF PROPERTY                                                                  7
ITEM 3:    LEGAL PROCEEDINGS                                                                        7
ITEM 4:    SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS                                      7
ITEM 5:    MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS                                 7
ITEM 6:    MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION                                8
ITEM 7:    FINANCIAL STATEMENTS                                                                    11
ITEM 8:    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES   29
ITEM 9:    DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS                            30
ITEM 10:   EXECUTIVE COMPENSATION                                                                  33
ITEM 11:   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT                          34
ITEM 12:   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS                                          35
ITEM 13:   EXHIBITS AND REPORTS                                                                    35
ITEM 14:   PRINCIPAL ACCOUNTANT FEES AND SERVICES                                                  35
</TABLE>



                    NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Form  10-KSB may  contain  certain  forward-looking  statements  within the
meaning  of the  Private  Securities  Litigation  Reform  Act of 1995.  For this
purpose any statements  contained in this Form 10-KSB that are not statements of
historical fact may be deemed to be forward-looking statements. Without limiting
the foregoing,  words such as "may," "will," "expect," "believe,"  "anticipate,"
"estimate"  or  "continue"  or  comparable  terminology  is intended to identify
forward-looking  statements.  It is  important  to note that our actual  results
could  differ  materially  from  those  anticipated  from  the   forward-looking
statements  depending on various  important  factors.  These  important  factors
include our history of losses and  ability to continue as a going  concern,  the
uncertainty   of  acceptance  of  current  and  new  products  in  our  markets,
competition  in our markets,  our dependence on our  distributors  and the other
factors discussed in our "Risk Factors" found on page 10.


                                       2
<PAGE>

FORWARD-LOOKING STATEMENTS

Portions  of  this  Form  10-KSB,   including   disclosure  under  "Management's
Discussion  and  Analysis  or  Plan  of  Operation,"   contain   forward-looking
statements  within the meaning of Section 27A of the  Securities Act of 1933, as
amended (the "Securities  Act"),  Section 21E of the Securities and Exchange Act
of 1934, as amended (the "Exchange Act"), and the Private Securities  Litigation
Reform Act of 1995, as amended. These forward-looking  statements are subject to
risks and  uncertainties  and other  factors that may cause our actual  results,
performance  or  achievements  to be  materially  different  from  the  results,
performance  or  achievements   expressed  or  implied  by  the  forward-looking
statements.  You  should not unduly  rely on these  statements.  Forward-looking
statements  involve  assumptions  and  describe  our  plans,   strategies,   and
expectations.  You can generally  identify a forward-looking  statement by words
such as may,  will,  should,  expect,  anticipate,  estimate,  believe,  intend,
contemplate  or project.  Factors,  risks,  and  uncertainties  that could cause
actual results to differ materially from those in the forward-looking statements
include, among others,

o        our ability to raise capital,

o        our ability obtain and retain customers,

o        our ability to provide our products and services at competitive rates,

o        our ability to execute our business strategy in a very competitive
         environment,

o        our degree of financial leverage,

o        risks associated with our acquiring and integrating companies into our
         own,

o        risks related to market acceptance and demand for our services,

o        the impact of competitive services,
o        other risks referenced from time to time in our SEC filings.


With respect to any  forward-looking  statement that includes a statement of its
underlying  assumptions  or  bases,  we  caution  that,  while we  believe  such
assumptions  or  bases to be  reasonable  and have  formed  them in good  faith,
assumed  facts  or  bases  almost  always  vary  from  actual  results,  and the
differences  between  assumed facts or bases and actual  results can be material
depending on the circumstances.  When, in any forward-looking  statement,  we or
our  management  express an  expectation  or belief as to future  results,  that
expectation  or belief is  expressed  in good  faith and is  believed  to have a
reasonable  basis, but there can be no assurance that the stated  expectation or
belief will result or be achieved or  accomplished.  All subsequent  written and
oral  forward-looking  statements  attributable  to us, or anyone  acting on our
behalf, are expressly qualified in their entirety by the cautionary  statements.
We do not undertake  any  obligations  to publicly  release any revisions to any
forward-looking  statements to reflect events or circumstances after the date of
this report or to reflect unanticipated events that may occur.


PART I

ITEM 1: DESCRIPTION OF BUSINESS

(a)  Business Development

Crown Medical  Systems,  Inc. (the "Company") was  incorporated on January 29th,
2002  under  the  laws of the  State of  Nevada  under  the  name of Link  Media
Publishing Ltd.

From the date of its  incorporation  to  February  29th,  2004 the  Company  has
undertaken the following activity:

(1) Through an agreement  dated  February 15, 2002 and completed on February 22,
2002,  we  acquired a 100% equity  interest  in Business to Business  Publishing
Inc.,  a private  British  Columbia  company  involved  in the  publication  and
distribution of industry and profession specific wall planners.


                                       3
<PAGE>

(2) During the fiscal year ended  February 28, 2003,  our  subsidiary  suspended
operations  due to our  failure  to raise  sufficient  working  capital  to fund
ongoing  operations  and our  inability  to  attain  profitable  operations.  We
attempted to raise additional financing to fund future operations,  but were not
successful.

(3) On July 14, 2003, the Company completed a 5:1 stock split of its outstanding
share  capital in  connection  with the proposed  acquisition  of Crown  Medical
Systems,  Inc.  resulting  in an  increase  in  outstanding  common  shares from
6,390,367 shares to 31,951,835 shares.

(4) On September 3, 2003,  the Company  executed an Agreement and Plan of Merger
(the "Merger  Agreement") with Crown Medical Systems,  Inc. ("Crown  Delaware").
Crown Delaware is a private  Delaware company that provides  computer  software,
hardware  and support  solutions  to the health care  industry.  Pursuant to the
terms of the Agreement,  the Company changed its name to Crown Medical  Systems,
Inc. effective December 18, 2003. The Merger Agreement is subject to approval of
the shareholders of Crown Delaware and a final closing.

Upon  final  closing,  the  acquisition  will  be  accounted  for  as a  reverse
acquisition with Crown Delaware being treated as the accounting parent and Crown
Medical Systems,  Inc. (Nevada) (the "Company),  the legal parent, being treated
as the accounting subsidiary.

(5)  Effective  December 18, 2003 the Company  changed its name to Crown Medical
Systems, Inc.

(6) The Company, through an agreement dated January 27, 2004 acquired the rights
to MD PaperFree,  a proprietary EMR (Electronic Medical Record) software program
used by Medical  Practitioners to document patient  encounters.  The company, on
the same date entered into a sub license  agreement with Crown Medical  Systems,
Inc. [Delaware] granting them the sole rights to market,  distribute and license
ownership and us of the MD PaperFree  software,  in exchange for a twelve (12) %
royalty  payable to the Company on all  proceeds  earned  from the MD  PaperFree
software.

(7) On  February  23,  2004  disposed  of its entire  interest  in the shares of
Business  to  Business   Publishing   Inc.  in  return  for  the  surrender  for
cancellation  of the 13,000,000  post forward split shares of the Company issued
in connection with the acquisition of Business to Business Publishing Inc.


(b) Business of Issuer

GENERAL

The Company is in the business of providing Medical  Practitioners with software
and associated hardware solutions, that meet or exceed security levels specified
by the Health Insurance Portability and Accountability Act of 1996.

(1)        Distribution Method of Services

In exchange  for a 12% royalty,  he company has granted an exclusive  license to
Crown  Medical  Systems,  Inc.  (Delaware)  to market  the MD  PaperFree(R)  EMR
software through the Delaware company's network of distributors.

(2) Principal Products or Services and Their Markets:

(i)        Principal Products or Services

The Company  will  generate  royalty  revenue  from the sale of its  proprietary
Electronic  Medical  Record  software,   to  physician  offices,   clinics,  and
hospitals.

(ii) Markets

Inside the Medical Practitioner  marketplace,  the Company's licessee will focus
upon  sole  practitioners,  doctors  and other  health  providers  operating  in
clinics, and small hospitals.

In addition to the normal risks  associated with a new business  venture,  there
can be no assurance that the Company's venture will be a commercial success.

In order to reach potential buyers, the company's licensee will use a network of
distributors acting as independent contractors,  who have existing relationships
within the medical practitioner arena.


                                       4
<PAGE>

(iii)      Business Applications of Services

Pursuant to the Health  Insurance  Portability and  Accountability  Act of 1996,
Medical  Practitioners  MD  PaperFree(R)  EMR is the Company's  proprietary  EMR
software  used by Medical  Practitioners  to  document  patient  encounters.  MD
PaperFree(R)  EMR was designed to enhance  physician  productivity  using tablet
PCs, or desktop workstations,  to automate the most common physician activities.
MD PaperFree(R) EMR replaces  paper-based  medical records and is available as a
hosted solution.

Designed to reduce the workload of all key staff members  within the  healthcare
provider  organization,  MD PaperFree(R) EMR features revenue  stabilization and
enhancement  tools,  as well as  built in  safeguards  to  significantly  reduce
potential  malpractice lawsuits and HIPAA violations.  Additionally,  physicians
can justify enhanced levels of patient billing due to more complete diagnosis.

(3)        Status Of Any Publicly Announced New Product Or Service

The company's exclusive license has an active website at www.crownmed.com

(4) Competitive  Business Conditions And The Small Business Issuer's Competitive
Position In The Industry And Methods Of Competition

Healthcare  provider markets are highly  competitive and  characterized by rapid
changes  due  to  regulation  and  technological  improvements.  The  healthcare
industry  is  currently  being  driven  by  process   optimization   initiatives
especially  as it  relates  to HIPAA  compliance,  reducing  medical  errors and
improving financial performance.

The Company's products and services compete with other healthcare software-based
companies currently in the market, as well as other companies that may enter the
market with emerging technologies. While the Company is more limited in terms of
operating history, financial resources, facilities and personnel relative to its
competitors,  its strategy is to compete  with larger  companies on the basis on
providing an integrated software,  hardware and service solution and its ability
to  provide   integration,   implementation  and  ongoing  system  and  database
maintenance through its ASP model.

(5)  Sources  and  availability  of raw  materials  and the  names of  principal
suppliers:

The  components  required to provide all of the  Company's  services are readily
available in the marketplace.

(8) Need for any government approval of principal products or services:

At this time there is no direct  required  government  approval of the  services
offered.  However,  the  Company's  ultimate  customers  operate  in the  highly
regulated Medical sector.

(9) Effect of existing or probable governmental regulations on the business:

Not applicable - see (8) above.

(10)  Estimate of the amount  spent  during each of the last two fiscal years on
research and development  activities,  and if applicable the extent to which the
cost of such activities are borne directly by customers:

The Company acquired the MD PaperFree(R) software at the end of its fiscal year.
No Research and Development activities were undertaken by the Company.

(11) Costs and effects of compliance with environmental laws (federal, state and
local):

There are no costs and effects of compliance with any environmental laws.


                                       5
<PAGE>

(12) Number of total employees and number of full time employees:

As of the date of this  Registration  Statement,  we do not  have any  employees
other than our directors and officers. All of our directors and officers provide
their services on an as needed basis.

RISK FACTORS

In addition to the other  information  in this  current  report,  the  following
factors should be carefully considered in evaluating our business and prospects:

Unsuccessful Operating History

We have a limited  operating  history  upon  which an  evaluation  of our future
prospects can be made. Our business  history has been limited to the publication
and  distribution  of industry  and  profession  specific  wall  planners.  That
business  plan was  unsuccessful  and we are now reviewing  the  possibility  of
resuming our operation and reviewing other business  acquisition  opportunities.
There is no guarantee  that we will be able to raise the financing  necessary to
develop any future business plan we may adopt.

If We Do Not Obtain  Additional  Financing,  We Will Not Be Able to Acquire  Any
Assets

As of February  29, 2004,  we had cash on hand in the amount of  $1,952.We  will
likely  have to raise  funds to  acquire  new assets and  finance  operation  or
acquire  new assets and to finance  operations.  If we are not able to raise the
funds  necessary  to fund our  business  objectives,  we may  have to delay  the
implementation of any future business plan.

We do not have any  arrangements  for  financing and we can provide no assurance
that we will be able to obtain the required  financing  when  needed.  Obtaining
additional financing will be subject to a number of factors, including:

*          Market conditions;

*          Investor acceptance of potential business assets; and

*          Investor sentiment.

These factors may make the timing,  amount,  terms and  conditions of additional
financing  unattractive  or  unavailable  to us.  If we are  not  successful  in
achieving  financing id operation or acquire  business  assets,  our development
will be delayed.

If We Are Unable To  Generate  Significant  Revenues  From Our  Operations,  Our
Business Will Fail.

If we are unable to generate  significant revenues from resumption of operations
or  any  business  interest  we  acquire,   we  will  not  be  able  to  achieve
profitability or continue operations.

Our Securities May Be Subject to Penny Stock Regulation.

If an active  trading  market for our  securities  develops and the price of our
common  stock  falls  below  $5.00 per share,  then we will be subject to "penny
stock"  regulation.   "Penny  stock"  rules  impose  additional  sales  practice
requirements  on  broker-dealers  who sell such securities to persons other than
established  customers and accredited  investors (generally those with assets in
excess of $1,000,000 or annual income  exceeding  $200,000 or $300,000  together
with a spouse).  For transactions covered by these rules, the broker-dealer must
make a special suitability determination for the purchase of such securities and
have received the purchaser's  written  consent to the transaction  prior to the
purchase.  Additionally,  for any  transaction  involving a penny stock,  unless
exempt,  the  rules  require  the  delivery,  prior  to  the  transaction,  of a
disclosure  schedule  prescribed by the  Commission  relating to the penny stock
market. The broker-dealer also must disclose the commissions payable to both the
broker-dealer and the registered  representative  and current quotations for the
securities.  Finally,  monthly  statements must be sent disclosing  recent price
information  on the limited  market in penny  stocks.  Consequently,  the "penny
stock" rules may restrict  the ability of  broker-dealers  to sell our shares of
common stock. The market price of our shares would likely suffer as a result.

FORWARD-LOOKING STATEMENTS

This  prospectus  contains  forward-looking  statements  that involve  risks and
uncertainties.  We use words such as anticipate,  believe, plan, expect, future,
intend and similar expressions to identify such forward-looking  statements. You
should not place too much  reliance  on these  forward-looking  statements.  Our
actual results are most likely to differ  materially  from those  anticipated in
these forward-looking  statements for many reasons, including the risks faced by
us described in the this Risk Factors section and elsewhere in this prospectus.


                                       6
<PAGE>

ITEM 2.  DESCRIPTION OF PROPERTY

The Company neither leases nor owns any real property.

ITEM 3.  LEGAL PROCEEDINGS

Not applicable.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None

PART II

ITEM 5: MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Market Information
Crowns's  common stock is quoted on the NASD OTC Bulletin Board under the symbol
"CWMS"(formerly  "LKME"). The table below gives the high and low bid information
for each fiscal  quarter for the past year.  The bid  information  was  obtained
fromand OTC Bulletin Board,  and reflects  inter-dealer  prices,  without retail
mark-up, mark-down or commission, and may not represent actual transactions.

----------------------------- ------------------ -------------- ----------------
Period Ended                  High               Low            Source
----------------------------- ------------------ -------------- ----------------
June 9, 2004                  0.69               0.47           Yahoo Finance
----------------------------- ------------------ -------------- ----------------
May 31, 2004                  1.85               0.36           Yahoo Finance
----------------------------- ------------------ -------------- ----------------
February 29, 2004             2.15               1.40           Yahoo Finance
----------------------------- ------------------ -------------- ----------------
November 30, 2003             3.04               1.45           Yahoo Finance
----------------------------- ------------------ -------------- ----------------
August 31, 2003               2.60               0.01           Yahoo Finance
----------------------------- ------------------ -------------- ----------------
May 31, 2003                  .01                0.01           Yahoo Finance
----------------------------- ------------------ -------------- ----------------

----------------------------- ------------------ -------------- ----------------

We have  approximately  97  shareholders of record as at the date of this annual
report.


                                       7
<PAGE>

Dividends

There are no  restrictions  in our  articles  of  incorporation  or bylaws  that
prevent us from declaring  dividends.  The Nevada Revised Statutes,  however, do
prohibit  us  from  declaring  dividends  where,  after  giving  effect  to  the
distribution of the dividend:

1. we would not be able to pay our debts as they become due in the usual  course
of business; or

2. our total assets would be less than the sum of our total liabilities plus the
amount  that would be needed to  satisfy  the  rights of  shareholders  who have
preferential rights superior to those receiving the distribution.

We have not declared any dividends,  and we do not plan to declare any dividends
in the foreseeable future.

ITEM 6: MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

Crown Medical  Systems,  Inc.  ("the  Company") was  incorporated  as Link Media
Publishing  Ltd.  in the state of Nevada on January  29,  2002.  Pursuant  to an
Agreement dated February 15, 2002, and completed  February 22, 2002, the Company
acquired  all of the  issued  and  outstanding  shares  of  Business-to-Business
Publishing  Ltd.  ("B2B"),   a  British   Columbia,   Canada   corporation,   in
consideration  of 2,600,000  (13,000,000  post split)  restricted  shares of its
common stock and by advancing  B2B with $50,000 in long-term  loans  carrying no
interest or fixed terms of  repayment.  As a result of the  transaction  B2B has
become a wholly owned  subsidiary of the Company and their  operations have been
merged.

The Company  through  B2B,  which has no salaried  employees,  was  considered a
start-up  corporation  involved in the production and  distribution  of industry
specific and special  interests wall  planners.  Revenue was generated by B2B by
selling  advertising  space  in  its  wall  planners.  The  wall  planners  were
distributed,  free of charge,  to  targeted  professionals  or  individuals  who
comprise the industry or interest  groups for which the planners  were  designed
and produced.

Prior to our  previous  fiscal year ended  February  28,  2003,  our  subsidiary
suspended  operations due to our failure to raise sufficient  working capital to
fund ongoing  operations and our inability to attain profitable  operations.  We
attempted  to raise  additional  financing  to fund and restart  the  publishing
operations, but were not successful.

On February  23,  2004 we  disposed of its  interest in the shares of B2B to its
original vendors, in return for the surrender for cancellation of the 13,000,000
post  forward  split  shares  of the  Company  issued  in  connection  with  the
acquisition  of Business to Business  Publishing  Inc.,  resulting  in a gain on
disposition  of  $2,495.  The B2B  operations  have been  shown as  discontinued
operations in the accompanying financial statements.

On September 3, 2003, the Company  executed an Agreement and Plan of Merger (the
"Merger Agreement") with Crown Medical Systems,  Inc. ("Crown Delaware").  Crown
Delaware is a private Delaware company that provides computer software, hardware
and support solutions to the health care industry.  Pursuant to the terms of the
Agreement, the Company changed its name to Crown Medical Systems, Inc. effective
December  18,  2003.  The  Merger  Agreement  is  subject  to  approval  of  the
shareholders of Crown Delaware and a final closing.

Upon  final  closing,  the  acquisition  will  be  accounted  for  as a  reverse
acquisition with Crown Delaware being treated as the accounting parent and Crown
Medical Systems,  Inc. (Nevada) (the "Company),  the legal parent, being treated
as the accounting subsidiary.

The Company,  through an agreement dated January 27, 2004 acquired MD PaperFree,
a proprietary EMR (Electronic  Medical Record)  software program used by Medical
Practitioners  to document  patient  encounters.  The company,  on the same date
entered into a sub license  agreement with Crown Delaware granting the exclusive
rights to market,  distribute and license  ownership and use of the MD PaperFree
software,  in exchange for a twelve (12) % royalty payable to the Company on all
licensing fees received by Crown from the MD PaperFree  software.  No sales took
place during the period between acquisition (January 27, 2004) and year-end, and
accordingly no royalties were earned.

For the year ended February 29, 2004, the Company had total assets of $1,501,952
(2003  $10,000),  including  cash  resources of $1,952 (2003  $3,392),  accounts
receivable  of $Nil ( 2003  $5,210) and Computer  Software of  $1,500,000 ( 2003
$695).  The cash  and  equivalents  represent  the  Company  present  source  of
liquidity.

The Company's  liabilities at February 29, 2004 totalled $49,172 ( 2003 $6,782),
consisting  of $36,172 ( 2003  $6,782) in accounts  payables  and $13,000 ( 2003
$Nil) in loans payables.

During the years ended  February  29, 2004 and February 28, 2003 the Company had
no revenues from continuing operations.  The Company incurred net losses for the
year from continuing  operations of $49,487 ( 2003 $9,567). The Company recorded
net income from discontinued operations of $484 after taking into account a gain
on disposition of discontinued operations of $2,495. During 2003 the Company had
a loss from discontinued operations of $73,204.


                                       8
<PAGE>

The  Company  has not  realized  any  revenues  for the  current  year and it is
presently  operating at a loss. The Company's  ability to continue as an ongoing
concern is dependent on its ability to generate  revenues from  software  sales.
Failing that, the Company may need to raise additional  capital,  either debt or
equity  capital,  to fund future  operation and ultimately to attain  profitable
operation.

On September 3, 2003, the Company  executed an Agreement and Plan of Merger (the
"Merger  Agreement") with Crown Delaware.  This Merger Agreement takes precedent
over the Share Purchase  Agreement  executed June 20, 2003.  Crown Delaware is a
private Delaware company that provides computer  software,  hardware and support
solutions  to the health  care  industry.  The  Agreement  and Plan of Merger is
subject  to  approval  of the  shareholders  of the Crown  Delaware  and a final
closing. The terms of the Merger Agreement provide for:

(a)   Forward share split - 5:1. The forward split took place on July 14, 2003.

(b)   Disposal of B2B - as a condition  precedent  to the  acquisition  of Crown
      Delaware,  the Company has disposed of its interest in B2B to the original
      vendors who are former  Directors of the Company in exchange for 2,600,000
      (13,000,000 post split)  restricted  common shares issued as consideration
      for the  acquisition of the B2B. The Company has cancelled the re-acquired
      shares, and the B2B nominated directors have resigned. (Refer to Note 5.)

(c)   Re-Purchase  of Shares - Upon  completion  of the  Merger  Agreement,  the
      Company  will  acquire for  treasury,  2,000,000  (10,000,000  post split)
      restricted common shares from a former director for nominal consideration.

(d)   Acquisition of Crown  Delaware - the current Crown  Delaware  shareholders
      will  receive  16,500,000  post  split  shares  as  consideration  for the
      acquisition,  on the basis of 0.7857 new share for each one current  Crown
      Delaware share of which 6,500,000 will be newly issued and 10,000,000 will
      come from the  treasury  shares  acquired  from a  Director  as more fully
      described  in 3 (c)  above.  These  shares  will be  subject  to rule  144
      restrictions.

(e)   Merger - each current  Company  shareholder  will receive one new share of
      the surviving company for each share they held in the Company prior to the
      acquisition of Crown Delaware. To date, the shareholders of Crown Delaware
      have not yet approved the merger.

(f)   Preferred  Shares  - The  Company  has  also  agreed  to  issue  5,000,000
      non-voting   non-participating   preferred   shares   to  Crown   Delaware
      management, convertible into common shares of the Company, on a one to one
      basis,  upon the  booking of  $10,000,000  of sales  revenue in any twelve
      month period.

(g)   Effective  December 18, 2003, the Company  executed a name change to Crown
      Medical Systems Inc. The Company's  trading symbol was changed to CWMS for
      trading on the Over The Counter Bulletin Board.

(h)   Options - Certain key employees and  consultants of Crown Delaware will be
      granted a total of 1,500,000  options to acquire  shares of The  Company's
      common stock at a price of $0.75 per share for a period of 60 months.

Upon completion of the transactions  described above, the former shareholders of
Crown Delaware will own approximately 65% (52% on a diluted basis) of the common
shares of the Company. As there will be a change in control of the Company,  the
transactions will be accounted for as a reverse merger with Crown Delaware being
treated as the accounting parent and the Company being treated as the accounting
subsidiary.


                                       9
<PAGE>

Plan of Operation

During the fiscal year ended February 29, 2004 we had no revenue.

We intend to seek financing  necessary to fund future operations and to fund our
investigation,   negotiation  and  acquisition  of  other  business  acquisition
opportunities.  Currently,  we have no anticipated source of financing and CROWN
DELAWARE XXX no specific business projects that are being reviewed.

We anticipate incurring  approximately $100,000 for administrative expenses over
the next 12 month period  including  accounting and audit costs  ($15,000) legal
fees ($25,000), rent and office costs ($35,000) and general administrative costs
($25,000).  We do not  currently  have cash on hand to cover  these  anticipated
costs.

We  anticipate  that  additional  funding will be required in the form of equity
financing from the sale of our common stock or from director loans.  However, we
cannot  provide  investors  with  any  assurance  that we will be able to  raise
sufficient  funding from the sale of our common stock or arrange  director loans
in order to continue operations.

Results of Operations

During the fiscal year ended  February  29, 2004 we earned no  revenues,  and we
incurred General and Administrative  Expenses of $49,487,  including  consulting
fees of $1,000,  office and general  costs of $18,697 and  professional  fees of
$29,790, resulting in a loss from continuing operations of $49,487. Although B2B
did not  operate  during the year,  it  incurred  $2,011 of losses,  which after
taking  into  account  a $2,495  gain on  disposition,  resulted  in a gain from
discontinued operations of $484.

For the fiscal year ended  February 28, 2003,  we earned  $11,796 from  business
operations  relating to our production and  distribution of wall planners.  This
amount was offset by general and  administrative  expenses of $94,561 consisting
of goodwill impairment of $41,075, accounting and legal costs of $15,784, office
and general costs of $12,137,  bad debt write offs totalling $9,327,  consulting
fees of $8,402, printing, design and distribution costs of $6,547 and travel and
promotion  costs of $1,289.  Accordingly,  we incurred a net loss of $82,765 for
the fiscal year.


                                       10
<PAGE>

ITEM 7: FINANCIAL STATEMENTS


                           CROWN MEDICAL SYSTEMS, INC.

                      (FORMALLY LINK MEDIA PUBLISHING LTD.)


                          (A DEVELOPMENT STAGE COMPANY)


                        CONSOLIDATED FINANCIAL STATEMENTS


                                FEBRUARY 29, 2004




INDEPENDENT AUDITORS' REPORT

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED STATEMENTS OF OPERATIONS

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

CONSOLIDATED STATEMENTS OF CASH FLOWS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS




                                       11
<PAGE>


                 [DALE MATHESON CARR-HILTON LABONTE LETTERHEAD]



INDEPENDENT AUDITORS' REPORT
--------------------------------------------------------------------------------


To the Board of  Directors  and  Stockholders  of Crown  Medical  Systems,  Inc.
(formerly Link Media Publishing Ltd.)

We have audited the consolidated  balance sheets of Crown Medical Systems,  Inc.
(formerly Link Media  Publishing  Ltd.), (a development  stage  company),  as at
February  29, 2004 and  February  28, 2003 and the  consolidated  statements  of
operations, stockholders' equity and cash flows for the years ended February 29,
2004 and February 28, 2003, and the period from January 29, 2002  (inception) to
February  29,   2004.   These   consolidated   financial   statements   are  the
responsibility of the Company's management.  Our responsibility is to express an
opinion on these financial statements based on our audits.

We conducted our audits in  accordance  with United  States  generally  accepted
auditing standards. Those standards require that we plan and perform an audit to
obtain  reasonable  assurance  whether  the  financial  statements  are  free of
material  misstatement.  An audit includes examining,  on a test basis, evidence
supporting  the amounts and  disclosures in the financial  statements.  An audit
also includes assessing the accounting principles used and significant estimates
made by  management,  as well as  evaluating  the  overall  financial  statement
presentation.  We believe  that our audits  provide a  reasonable  basis for our
opinion.

In our opinion,  these consolidated  financial statements present fairly, in all
material respects, the financial position of the Company as at February 29, 2004
and February 28, 2003 and the results of its  operations  and its cash flows and
the changes in  stockholders'  equity for the years ended  February 29, 2004 and
February 28, 2003, and the period from January 29, 2002  (inception) to February
29, 2004.

The accompanying  consolidated  financial statements have been prepared assuming
that the Company will continue as a going concern. As discussed in Note 1 to the
financial  statements,  to date the Company has not  generated  any  significant
revenues from operations and requires  additional  funds to meet its obligations
and the costs of its operations. These factors raise substantial doubt about the
Company's  ability to continue as a going  concern.  Management's  plans in this
regard are  described  in Note 1. The  financial  statements  do not include any
adjustments that might result from the outcome of this uncertainty.



                                       12
<PAGE>





                                             "Dale Matheson Carr-Hilton LaBonte"



                                                           CHARTERED ACCOUNTANTS







Vancouver, B.C.

May 31, 2004


                                       13
<PAGE>


                           CROWN MEDICAL SYSTEMS, INC.

                      (FORMERLY LINK MEDIA PUBLISHING LTD.)

                          (A DEVELOPMENT STAGE COMPANY)

                           CONSOLIDATED BALANCE SHEETS

<TABLE>
<CAPTION>
                                                                                          February 29,         February 28,
                                                                                              2004                 2003
  ---------------------------------------------------------------------------------- ------------------- --------------------

<S>                                                                                           <C>                 <C>
  ASSETS

  CURRENT ASSETS
      Cash                                                                                    $  1,952            $   3,372
      Accounts receivable                                                                            -                5,210
      Other receivables                                                                              -                  723
  ---------------------------------------------------------------------------------- ------------------- --------------------
                                                                                                 1,952                9,305
  COMPUTER SOFTWARE (Note 4)                                                                 1,500,000                    -
  FIXED ASSETS                                                                                       -                  695
  ---------------------------------------------------------------------------------- ------------------- --------------------

                                                                                           $ 1,501,952           $   10,000
  ================================================================================== =================== ====================


                                           LIABILITIES AND STOCKHOLDERS' EQUITY

  CURRENT LIABILITIES
      Accounts payable and accrued liabilities                                               $  36,172            $   6,782
      Due to related parties (Note 5)                                                           13,000                    -
  ---------------------------------------------------------------------------------- ------------------- --------------------
                                                                                                49,172                6,782
  ---------------------------------------------------------------------------------- ------------------- --------------------

  GOING CONCERN CONTINGENCIES AND COMMITMENTS (Notes 1 and 9)

  STOCKHOLDERS' EQUITY
      Capital stock (Note 7)
         Common stock, $0.001 par value,  70,000,000 shares authorized Preferred
         stock, $0.001 par value, 5,000,000 shares authorized 20,451,835 (2003 -
         31,951,835) post-split common shares issued and outstanding
                                                                                                 5,290                6,390
       Additional paid-in capital                                                            1,585,320               86,820
  Other comprehensive income (loss)                                                                  -               (1,165)
  Deficit accumulated during the development stage                                            (137,830)             (88,827)
  ---------------------------------------------------------------------------------- ------------------- --------------------

                                                                                             1,452,780                3,218
  ---------------------------------------------------------------------------------- ------------------- --------------------

                                                                                            $ 1,501,952          $   10,000
  ================================================================================== =================== ====================
</TABLE>




   The accompanying notes are an integral part of these consolidated financial
                                   statements.

                                       14
<PAGE>

                          CROWN MEDICAL SYSTEMS, INC.

                     (FORMERLY LINK MEDIA PUBLISHING LTD.)

                         (A DEVELOPMENT STAGE COMPANY)

                       STATEMENT OF STOCKHOLDERS' EQUITY

     FOR THE PERIOD FROM JANUARY 29, 2002 (INCEPTION) TO FEBRUARY 29, 2004


<TABLE>
<CAPTION>
                                                                                                               Deficit
                                                                                                             Accumulated
                                             Common stock         Additional      Share          Other          During
                                                                   Paid-In    Subscriptions  Comprehensive   Development
                                           Shares     Amount       Capital      Received         Income         Stage        Total
-----------------------------------------------------------------------------------------------------------------------------------
<S>                                     <C>         <C>        <C>            <C>            <C>            <C>          <C>
Issuance of common stock for cash at
$.001 per share
- February 12, 2002                     3,500,000   $  3,500   $        --    $       --     $       --     $      --    $    3,500

Issuance of common stock for
acquisition of Business to Business
Publishing Inc. at $.001 per share
- February 22, 2002                     2,600,000      2,600            --            --             --            --         2,600

Share subscriptions received                   --         --            --        71,300             --            --        71,300

Net loss for the period January 29,
2002 (inception) to February 28,
2002                                           --         --            --            --             --        (6,062)       (6,062)
-----------------------------------------------------------------------------------------------------------------------------------

Balance, February 28, 2002              6,100,000      6,100            --        71,300            --         (6,062)       71,338


Issuance  of common  stock for cash
at $.30 per share - March 30, 2002        290,367        290        86,820       (71,300)            --            --        15,810

Other comprehensive income (loss)              --         --            --            --         (1,165)           --        (1,165)

Net loss for the year ended
February 28, 2003                              --         --            --            --             --       (82,765)      (82,765)
-----------------------------------------------------------------------------------------------------------------------------------

Balance, February 28, 2003              6,390,367      6,390        86,820            --         (1,165)      (88,827)        3,218

Stock split 5:1 - July 14, 2003        25,561,468         --            --
---------------------------------------------------------------------------

                                       31,951,835      6,390        86,820
</TABLE>


                                       15
<PAGE>

<TABLE>
<CAPTION>
                                                                                                               Deficit
                                                                                                             Accumulated
                                             Common stock         Additional      Share          Other          During
                                                                   Paid-In    Subscriptions  Comprehensive   Development
                                           Shares     Amount       Capital      Received         Income         Stage        Total
-----------------------------------------------------------------------------------------------------------------------------------
<S>                                     <C>         <C>        <C>            <C>            <C>            <C>          <C>
Issuance of common stock for
Acquisition of MD Paper Free -
January 28, 2004                        1,500,000      1,500     1,498,500            --             --            --     1,500,000

Surrender and cancellation
 of common stock on sale of
Business to Business Publishing
Inc. at $.001 per share -
February 23, 2004                     (13,000,000)    (2,600)           --            --             --            --        (2,600)

Other comprehensive income (loss)              --         --            --            --          1,165            --         1,165

Net loss for the year ended
February 29, 2004                              --         --            --            --             --       (49,003)      (49,003)
-----------------------------------------------------------------------------------------------------------------------------------

Balance, February 29, 2004             20,451,835   $  5,290   $ 1,585,320    $       --     $       --     $(137,830)   $1,452,780
====================================================================================================================================
</TABLE>


The  accompanying  notes are an integral  part of these  consolidated  financial
statements.


                                       16
<PAGE>



                           CROWN MEDICAL SYSTEMS, INC.

                      (FORMERLY LINK MEDIA PUBLISHING LTD.)

                          (A DEVELOPMENT STAGE COMPANY)

                      CONSOLIDATED STATEMENTS OF CASH FLOWS







<TABLE>
<CAPTION>
                                                                                                             January 29, 2002
                                                                     Year ended    Year ended February         (Inception) to
                                                              February 29, 2004               28, 2003      February 29, 2004
==============================================================================================================================
<S>                                                                 <C>                     <C>                   <C>
CASH FLOWS FROM OPERATING ACTIVITIES
   Net loss for the year from continuing operations                 $  (49,487)             $  (9,561)            $  (65,110)
   Adjusted for items not involving cash:
       Depreciation                                                        695                     77                    772
       Goodwill impairment                                                  --                 41,075                 41,075
------------------------------------------------------------------------------------------------------------------------------

                                                                       (48,792)                31,591                (23,264)
       Net changes in non-cash working capital items                    34,577                 (4,455)                36,172
------------------------------------------------------------------------------------------------------------------------------

Cash used for continuing operations                                    (14,215)               (27,136)                12,908
Discontinued operations                                                 (1,370)               (38,076)               (93,717)
------------------------------------------------------------------------------------------------------------------------------

                                                                       (15,585)               (65,212)               (80,809)
------------------------------------------------------------------------------------------------------------------------------

CASH FLOWS FROM INVESTING ACTIVITIES
   Acquisition of equipment                                                 --                   (772)                  (772)
   Net advances to B2B prior to acquisition                                 --                     --                (20,077)
------------------------------------------------------------------------------------------------------------------------------

NET CASH FLOWS USED IN INVESTING ACTIVITIES                                 --                   (772)               (20,849)
------------------------------------------------------------------------------------------------------------------------------
</TABLE>

                                       17
<PAGE>

<TABLE>
<CAPTION>

                                                                                                             January 29, 2002
                                                                     Year ended    Year ended February         (Inception) to
                                                              February 29, 2004               28, 2003      February 29, 2004
==============================================================================================================================
<S>                                                                 <C>                     <C>                   <C>
CASH FLOWS FROM FINANCING ACTIVITIES
   Proceeds from common share subscriptions and issuances                   --                 15,810                 90,610
   Net advances from (repayments to) related parties                    13,000                     --                 13,000
------------------------------------------------------------------------------------------------------------------------------

NET CASH FLOWS FROM FINANCING ACTIVITIES                                13,000                 15,810                103,610
------------------------------------------------------------------------------------------------------------------------------

EFFECT OF FOREIGN EXCHANGE RATE CHANGES ON CASH                          1,165                 (1,165)                    --
------------------------------------------------------------------------------------------------------------------------------

INCREASE (DECREASE) IN CASH                                             (1,420)               (51,339)                 1,952

CASH, BEGINNING OF YEAR                                                  3,372                 54,711                     --
------------------------------------------------------------------------------------------------------------------------------

CASH, END OF YEAR                                                   $    1,952              $   3,372             $    1,952
==============================================================================================================================
</TABLE>


Supplemental cash flow information (Note 10).


The  accompanying  notes are an integral  part of these  consolidated  financial
statements.

                                       18
<PAGE>

                           CROWN MEDICAL SYSTEMS, INC.

                      (FORMERLY LINK MEDIA PUBLISHING LTD.)

                          (A DEVELOPMENT STAGE COMPANY)

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                                FEBRUARY 29, 2004
--------------------------------------------------------------------------------


NOTE 1 - NATURE OF OPERATIONS AND BASIS OF PRESENTATION


The Company,  through an  agreement  dated  February  15, 2002 and  completed on
February  22,  2002,  acquired  100% of the  issued  and  outstanding  shares of
Business  to Business  Publishing  Inc.  ("B2B"),  a private  British  Columbia,
Canada,  company  involved in the business of  publishing  specialized  interest
publications  targeting  particular  readership in exchange for 2,600,000 shares
(13,000,000 post split shares) of the Company.  On February 23, 2004 the Company
disposed of its entire interest in the shares of B2B in return for the surrender
for  cancellation  of 13,000,000  Company  shares of restricted  stock issued in
connection with the acquisition of B2B.

On September 3, 2003, the Company  executed an Agreement and Plan of Merger (the
"Merger Agreement") with Crown Medical Systems,  Inc. ("Crown Delaware").  Crown
Delaware is a private Delaware company that provides computer software, hardware
and support solutions to the health care industry.  Pursuant to the terms of the
Agreement, the Company changed its name to Crown Medical Systems, Inc. effective
December  18,  2003.  The  Merger  Agreement  is  subject  to  approval  of  the
shareholders of Crown Delaware and a final closing.
(Refer to Note 3.)

Upon  final  closing,  the  acquisition  will  be  accounted  for  as a  reverse
acquisition with Crown Delaware being treated as the accounting parent and Crown
Medical Systems,  Inc. (Nevada) (the "Company),  the legal parent, being treated
as the accounting subsidiary.

The Company, through an agreement dated January 12, 2004 and amended January 27,
2004,  acquired a proprietary EMR (Electronic  Medical Record)  software program
("MD  Paperfree")  to be  marketed  to  medical  practitioners  for their use in
documenting  patient  encounters.  The Company,  on the same date entered into a
sub-license  agreement  with Crown  Delaware,  pending  completion of the Merger
Agreement,  granting  Crown  Delaware the sole rights to market,  distribute and
license ownership and use of the MD Paperfree software, in exchange for a twelve
(12)%  royalty  payable to the Company on all  licensing  fees received by Crown
Delaware.

                                       19
<PAGE>

GOING CONCERN

These  financial  statements  have been  prepared in accordance  with  generally
accepted accounting principles in the United States of America with the on-going
assumption  applicable to a going concern which  contemplates the realization of
assets and the  satisfaction of liabilities and commitments in the normal course
of business.  The continued  operations of the Company and the recoverability of
the  carrying  value of assets is  dependent  upon the ability of the Company to
obtain  necessary  financing to fund future  operations and ultimately to attain
profitable  operations.  To February 29, 2004, the Company has a working capital
deficit of $47,220 and has incurred losses since inception  totalling  $137,830.
Management's  plans include obtaining  additional capital through debt or equity
financing.

The Company will depend almost  exclusively  on outside  capital to complete the
development and marketing of its proprietary software and related products. Such
outside  capital  will  include  the sale of  additional  stock and may  include
commercial  borrowing.  There can be no assurance that capital will be available
as necessary to meet these  development  costs or, if the capital is  available,
that it will be on terms acceptable to the Company.  The issuances of additional
equity  securities  by the Company may result in a  significant  dilution in the
equity  interests  of its  current  stockholders.  Obtaining  commercial  loans,
assuming those loans would be available, will increase the Company's liabilities
and future cash commitments. If the Company is unable to obtain financing in the
amounts and on terms deemed  acceptable,  the business and future success may be
adversely affected.

Given the Company's limited operating history,  lack of sales, and its operating
losses,  there can be no  assurance  that it will be able to achieve or maintain
profitability.  Accordingly,  these  factors raise  substantial  doubt about the
Company's ability to continue as a going concern.

                                       20
<PAGE>

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


BASIS OF PRESENTATION

The accompanying financial statements are presented in United States dollars and
are prepared in accordance with accounting  principles generally accepted in the
United States.


PRINCIPLES OF CONSOLIDATION

The financial  statements include the accounts of the Company,  and the accounts
of its wholly owned  subsidiary  B2B up to February  23,  2004,  the date it was
disposed  of  (Refer  to Note 6).  All  significant  intercompany  balances  and
transactions are eliminated on consolidation.


ORGANIZATION

The Company  was  incorporated  on January 29, 2002 in the State of Nevada.  The
Company's  fiscal year end is February  28 with its  initial  period  being from
January 29, 2002 (inception) to February 28, 2002.


COMPUTER SOFTWARE

In accordance  with  Statement of Position (SOP) No. 98-1,  "Accounting  for the
Costs of Computer Software Developed or Obtained for Internal Use" and Statement
of Financial  Accounting  Standards ("SFAS") No. 86, software  development costs
are expensed as incurred until  technological  feasibility has been established,
at which  time such  costs are  capitalized  until  commercial  operations  have
commenced.  These  capitalized  costs are  subject to an ongoing  assessment  of
recoverability  based on anticipated future revenues and changes in hardware and
software  technologies.  Software  development costs capitalized  include direct
labour and purchased software expenses incurred after technological  feasibility
has been established. Amortization of capitalized software costs begins upon the
commencement of commercial operations.  Capitalized costs will be amortized over
the  estimated  product  life of three to five  years,  using the greater of the
straight-line method or the ratio of current product revenues to total projected
future  revenues.  At the balance  sheet date,  the  Company  evaluates  the net
realizable  value of the  capitalized  costs  and  adjusts  the  current  period
amortization for any impairment of the capitalized asset value.  During 2004 the
Company capitalized software acquisition costs totalling $1,500,000.  During the
year ended February 29, 2004 the management has determined that no impairment in
the carrying value of capitalized computer application software had occurred.

                                       21
<PAGE>

REVENUE RECOGNITION

Upon the  completion of the proposed  acquisition  of Crown Delaware the Company
will  derive  its  revenues  from the  sale of  products,  license  fees for its
products, maintenance, support and services.

Revenues from product  sales will be  recognized  in  accordance  with SEC Staff
Accounting Bulletin No. 101 "Revenue Recognition in Financial  Statements" ("SAB
101") when delivery has occurred,  persuasive evidence of an arrangement exists,
the vendor's fee is fixed or determinable,  no further  obligation  exists,  and
collectibility is reasonably assured. When a right of return exists, the Company
defers revenues until the right of return expires.  Revenues  subject to certain
price  protection and stock rotation are deferred until products are sold by the
distributor, or until the right expires.

Revenue from license fees will be  recognized in  accordance  with  Statement of
Position (SOP 97-2 "Software Revenue Recognition"),  when persuasive evidence of
an  agreement  exists,  delivery  of the product has  occurred,  no  significant
obligations  with  regard  to  implementation   remain,  the  fee  is  fixed  or
determinable, and collectibility is probable.

Revenues  from  maintenance  and support will be  recognized on a pro rata basis
over the period of the maintenance contract.

Revenues  from  software  licenses  that  require   significant   customization,
integration and installation will be recognized as they are completed.

Initially,  pursuant  to the  MD  PaperFree  sub-license  agreement  with  Crown
Delaware  (refer to Note 4), the  Company  will  record  software  royalties  as
revenue when license fees are collected by Crown Delaware.


OTHER COMPREHENSIVE INCOME
Other comprehensive  income refers to revenue,  expenses,  gains and losses that
under  generally  accepted  accounting  principles are recorded as an element of
shareholders'  equity but are excluded  from net income.  To date the  Company's
other  comprehensive   income  is  comprised  of  foreign  currency  translation
adjustments  resulting  from  translation  of  the  foreign  currency  financial
statements of B2B.


USE OF ESTIMATES AND ASSUMPTIONS

Preparation of the Company's  financial  statements in conformity with generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions that affect certain  reported  amounts and disclosures.  Significant
items  requiring  management  estimates  include the carrying  value of computer
software and the fair values of common  share  issuances.  Financial  results as
determined by actual events could differ from those estimates.


CASH AND CASH EQUIVALENTS

The Company considers all liquid investments, with an original maturity of three
months or less when purchased, to be cash equivalents.

                                       22
<PAGE>

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT'D)

FOREIGN CURRENCY TRANSLATION

The financial  statements are presented in United States dollars.  In accordance
with  Statement of Financial  Accounting  Standards  No. 52,  "Foreign  Currency
Translation", foreign denominated monetary assets and liabilities are translated
to their United States dollar  equivalents  using foreign exchange rates,  which
prevailed at the balance  sheet date.  Revenue and expenses  are  translated  at
average rates of exchange during the year. Related  translation  adjustments are
reported as a separate  component  of  stockholders'  equity,  whereas  gains or
losses resulting from foreign  currency  transactions are included in results of
operations.

FAIR VALUE OF FINANCIAL INSTRUMENTS

In accordance with the  requirements of SFAS No. 107, the Company has determined
the  estimated  fair  value of  financial  instruments  using  available  market
information and appropriate valuation methodologies. The fair value of financial
instruments  classified as current  assets or liabilities  approximate  carrying
value due to the short-term maturity of the instruments.


NET LOSS PER COMMON SHARE

Basic earnings per share includes no dilution and is computed by dividing income
available to common stockholders by the weighted average number of common shares
outstanding for the period.  Dilutive  earnings per share reflects the potential
dilution of securities that could share in the earnings of the Company.  Because
the Company does not have any potentially dilutive securities,  the accompanying
presentation  is only of basic loss per  share.  Net loss per share for the year
ended February 28, 2003 has been restated to give retroactive  effect to the 5:1
stock split in 2004.


STOCK-BASED COMPENSATION

In December  2002, the Financial  Accounting  Standards  Board issued  Financial
Accounting  Standard  No.  148,  "Accounting  for  Stock-Based   Compensation  -
Transition  and  Disclosure"   ("SFAS  No.  148"),  an  amendment  of  Financial
Accounting Standard No. 123 "Accounting for Stock-Based Compensation" ("SFAS No.
123").  The  purpose of SFAS No. 148 is to: (1) provide  alternative  methods of
transition for an entity that voluntarily changes to the fair value based method
of accounting for stock-based  employee  compensation,  (2) amend the disclosure
provisions  to require  prominent  disclosure  about the effects on reported net
income of an entity's  accounting  policy  decisions with respect to stock-based
employee compensation, and (3) to require disclosure of those effects in interim
financial information.  The disclosure provisions of SFAS No. 148 were effective
for the Company commencing December 31, 2002.

The  Company  has  elected to  continue  to  account  for  stock-based  employee
compensation  arrangements  in  accordance  with the  provisions  of  Accounting
Principles  Board Opinion No. 25,  "Accounting  for Stock Issued to  Employees",
("APB No.  25") and comply  with the  disclosure  provisions  of SFAS No. 123 as
amended by SFAS No. 148 as described above. In addition, in accordance with SFAS
No. 123 the  Company  applies  the fair  value  method  using the  Black-Scholes
option-pricing model in accounting for options granted to consultants. Under APB
No. 25, compensation  expense is recognized based on the difference,  if any, on
the date of grant  between the estimated  fair value of the Company's  stock and
the amount an employee  must pay to acquire the stock.  Compensation  expense is
recognized  immediately  for past services and pro-rata for future services over
the option-vesting period.

The Company  has not  adopted a stock  option plan and has not granted any stock
options  since  inception.  Accordingly  no  stock-based  compensation  has been
recorded in any period.

                                       23
<PAGE>

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT'D)

INCOME TAXES

The Company follows the liability  method of accounting for income taxes.  Under
this method,  deferred tax assets and  liabilities are recognized for the future
tax  consequences  attributable to differences  between the financial  statement
carrying  amounts of existing assets and  liabilities  and their  respective tax
balances.  Deferred tax assets and  liabilities  are measured  using  enacted or
substantially  enacted tax rates  expected to apply to the taxable income in the
years in which those  differences  are expected to be recovered or settled.  The
effect  on  deferred  tax  assets  and  liabilities  of a change in tax rates is
recognized  in income in the  period  that  includes  the date of  enactment  or
substantial enactment. A valuation allowance is provided for deferred tax assets
if it is more  likely  than not that the  Company  will not  realize  the future
benefit, or if future deductibility is uncertain.


GOODWILL

In July 2001, the FASB issued  Statement of Financial  Accounting  Standards No.
142 ("SFAS 142"), "Goodwill and Intangible Assets", which revises the accounting
for  purchased  goodwill and  intangible  assets.  Under SFAS 142,  goodwill and
intangible  assets with indefinite lives will no longer be amortized and will be
tested for impairment annually or whenever events or circumstances indicate that
the estimated  fair value is less than the related  carrying value as determined
on a reporting unit basis. During fiscal 2003 the Company recorded an impairment
of goodwill relating to B2B. (Refer to Note 6)


COMPARATIVE FIGURES

Certain of the comparative  figures have been restated to conform to the current
year's presentation.


RECENT ACCOUNTING PRONOUNCEMENTS

In June 2002,  the FASB issued SFAS No. 146,  "Accounting  for Costs  Associated
with Exit or Disposal  Activities." Such standard requires costs associated with
exit or disposal activities (including restructurings) to be recognized when the
costs are  incurred,  rather than at a date of commitment to an exit or disposal
plan.  SFAS No. 146 nullifies EITF Issue No. 94-3,  "Liability  Recognition  for
Certain  Employee  Termination  Benefits  and  Other  Costs to Exit an  Activity
(including  Certain Costs Incurred in a  Restructuring)."  Under SFAS No. 146, a
liability  related to an exit or disposal  activity is not recognized until such
liability  has actually been  incurred and becomes  determinable,  whereas under
EITF Issue No. 94-3 a liability  was  recognized at the time of commitment to an
exit or disposal plan. The provisions of this standard are effective for exit or
disposal activities  initiated after December 31, 2002. The adoption of SFAS 146
has not had any  impact  on the  Company's  financial  position  or  results  of
operations.


On April 30, 2003, the FASB issued SFAS No. 149,  "Amendment of Statement 133 on
Derivative  Instruments  and  Hedging  Activities".  SFAS  No.  149  amends  and
clarifies  accounting for derivative  instruments,  including certain derivative
instruments  embedded in other contracts,  and for hedging activities under SFAS
No. 133. The new guidance  amends SFAS No. 133 for decisions made as part of the
Derivatives  Implementation  Group  ("DIG")  process that  effectively  required
amendments  to SFAS No. 133, and decisions  made in  connection  with other FASB
projects   dealing  with   financial   instruments   and  in   connection   with
implementation issues raised in relation to the application of the definition of
a derivative that contains financing components.  In addition, it clarifies when
a derivative  contains a financing  component that warrants special reporting in
the statement of cash flows.  SFAS No. 149 is effective  for  contracts  entered
into or modified  after June 30, 2003 and for hedging  relationships  designated
after June 30, 2003. The Company adopted SFAS 149, as required,  on July 1, 2003
with no material impact on its financial statements.

                                       24
<PAGE>

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT'D)

In May 2003,  SFAS 150,  "Accounting  for  Certain  Financial  Instruments  with
Characteristics  of both  Liabilities  and Equity",  was issued.  This Statement
establishes  standards  for  how  an  issuer  classifies  and  measures  certain
financial  instruments with  characteristics  of both liabilities and equity. It
requires that an issuer classify a financial instrument that is within its scope
as a liability (or an asset in some  circumstances).  Many of those  instruments
were previously classified as equity. Generally, a financial instrument, whether
in the form of shares or otherwise,  that is mandatorily  redeemable,  i.e. that
embodies  an  unconditional  obligation  requiring  the  issuer  to redeem it by
transferring its shares or assets at a specified or determinable date (or dates)
or upon an event that is certain to occur, must be classified as a liability (or
asset in some  circumstances).  In some cases,  a financial  instrument  that is
conditionally  redeemable  may  also be  subject  to the  same  treatment.  This
Statement does not apply to features that are embedded in a financial instrument
that is not a derivative (as defined) in its entirety. For public entities, this
Statement is effective for financial  instruments entered into or modified after
May 31, 2003.  The adoption of SFAS 150 has not had any impact on the  Company's
financial position or results of operations.

In  November  2002,  the FASB issued FASB  Interpretation  No. 45,  "Guarantor's
Accounting  for  Disclosure  Requirements  for  Guarantees,  Including  Indirect
Guarantees of Indebtedness of Others,  an  interpretation of FASB Statements No.
5, 57 and 107 and  rescission  of FASB  Interpretation  No.  34,  Disclosure  of
Indirect  Guarantees of Indebtedness of Others" ("FIN 45"). FIN 45 clarifies the
requirements  for a  guarantor's  accounting  for, and  disclosure  of,  certain
guarantees issued and outstanding. It also requires a guarantor to recognize, at
the inception of a guarantee,  a liability for the fair value of the  obligation
undertaken  in issuing the  guarantee.  This  interpretation  also  incorporates
without  reconsideration  the guidance in FASB  Interpretation  No. 34, which is
being superseded. The adoption of FIN 45 has not had any impact on the Company's
financial position or results of operations.

In January 2003, the FASB issued FASB  Interpretation  No. 46,  Consolidation of
Variable Interest Entities,  an interpretation of Accounting  Research Bulletins
("ARB") No. 51,  Consolidated  Financial  Statements  ("FIN 46"). Fin 46 applies
immediately to variable interest entitles created after January 31, 2003, and in
the first interim  period  beginning  after June 15, 2003 for variable  interest
entities created prior to January 31, 2003. The  interpretation  explains how to
identify variable interest entities and how an enterprise  assesses its interest
in a variable interest entity to decide whether to consolidate that entity.  The
interpretation requires existing unconsolidated variable interest entities to be
consolidated by their primary  beneficiaries  if the entities do not effectively
disperse  risks  among  parties   involved.   Variable  interest  entities  that
effectively  disperse risks will not be consolidated unless a single party holds
an interest or combination of interests that  effectively  recombines risks that
were previously dispersed.  The adoption of FIN 46 has not had any impact on the
Company's financial position or results of operations.


NOTE 3 - PROPOSED ACQUISITION OF CROWN DELAWARE

On September 3, 2003, the Company  executed an Agreement and Plan of Merger (the
"Agreement") with Crown Delaware.  This Agreement  supercedes the original Share
Purchase  Agreement executed June 20, 2003. Crown Delaware is a private Delaware
company that provides computer  software,  hardware and support solutions to the
health care industry. The Agreement and Plan of Merger is subject to approval of
the shareholders of the Company and a final closing.  The terms of the agreement
provide for:

(a)   Forward share split - 5:1. The forward split took place on July 14, 2003.

                                       25
<PAGE>

NOTE 3 - PROPOSED ACQUISITION OF CROWN DELAWARE (cont'd)

(b)   Disposal of B2B - as a condition  precedent  to the  acquisition  of Crown
      Delaware,  the Company has disposed of its interest in B2B to the original
      vendors who are former  Directors of the Company in exchange for 2,600,000
      (13,000,000 post split)  restricted  common shares issued as consideration
      for the  acquisition of the B2B. The Company has cancelled the re-acquired
      shares, and the B2B nominated directors have resigned. (Refer to Note 5.)

(c)   Re-Purchase  of Shares - Upon  completion of the merger,  the Company will
      acquire for treasury,  2,000,000 (10,000,000 post split) restricted common
      shares from a former director for nominal consideration.

(d)   Acquisition of Crown  Delaware - the current Crown  Delaware  shareholders
      will  receive  16,500,000  post  split  shares  as  consideration  for the
      acquisition,  on the basis of 0.7857 new share for each one current  Crown
      Delaware share of which 6,500,000 will be newly issued and 10,000,000 will
      come from the  treasury  shares  acquired  from a  Director  as more fully
      described  in 3 (c)  above.  These  shares  will be  subject  to rule  144
      restrictions.

(e)   Merger - each current  Company  shareholder  will receive one new share of
      the surviving company for each share they held in the Company prior to the
      acquisition of Crown Delaware. To date, the shareholders of Crown Delaware
      have not yet approved the merger.

(f)   Preferred  Shares  - The  Company  has  also  agreed  to  issue  5,000,000
      non-voting   non-participating   preferred   shares   to  Crown   Delaware
      management, convertible into common shares of the Company, on a one to one
      basis,  upon the  booking of  $10,000,000  of sales  revenue in any twelve
      month period.

(g)   Effective  December 18, 2003, the Company  executed a name change to Crown
      Medical Systems Inc. The Company's  trading symbol was changed to CWMS for
      trading on the Over The Counter Bulletin Board.

(h)   Options - Certain key employees and  consultants of Crown Delaware will be
      granted a total of 1,500,000  options to acquire  shares of The  Company's
      common stock at a price of $0.75 per share for a period of 60 months.

Upon completion of the transactions  described above, the former shareholders of
Crown Delaware will own approximately 65% (52% on a diluted basis) of the common
shares of the Company. As there will be a change in control of the Company,  the
transactions will be accounted for as a reverse merger with Crown Delaware being
treated as the accounting parent and the Company being treated as the accounting
subsidiary.

NOTE 4 - COMPUTER SOFTWARE
                                        February 29, 2004    February 28, 2003
                                       -------------------- --------------------
Capitalized costs                             $ 1,500,000              $    --
Less: accumulated amortization                         --                   --
                                       -------------------- --------------------

                                              $ 1,500,000              $    --
                                       ==================== ====================


By agreement  dated January 12, 2004 and amended  January 27, 2004,  the Company
purchased a 100% interest in MD  Paperfree,  a  proprietary  Electronic  Medical
Record (EMR) software program, to be marketed to medical practitioners for their
use in  documenting  patients'  encounters  and replacing  existing  paper-based
patient charts.  The  consideration  paid was 1,500,000  shares of the Company's
common  stock with a fair value of $1.00 per share.  As of  February  29,  2004,
capitalized software costs have not been amortized because commercial operations
have not yet commenced.



The Company  entered into a license  agreement with Crown Delware on January 27,
2004 granting  Crown  Delaware the exclusive  rights to market,  distribute  and
license  ownership  and use of the MD  Paperfree  software.  The Company will be
entitled to receive as a royalty a monthly  amount equal to twelve percent (12%)
of the Licensing  Fees actually  received by Crown Delaware from all field or on
site stand alone installations of MD Paperfree or its derivatives at any medical
facility.


                                       26
<PAGE>


NOTE 5 - RELATED PARTY TRANSACTIONS

Upon  acquisition  of B2B the directors of B2B were  appointed  directors of the
Company. These directors resigned upon the disposal of B2B by the Company.

Notes Payable:

$9,000 - due to a minority shareholder, interest free, without specific terms of
repayment

$4,000 - due to a former  director and secretary of the company,  interest free,
without specific terms of repayment

NOTE 6 - BUSINESS TO BUSINESS PUBLISHING INC.

                                       27
<PAGE>

The Company,  through an  agreement  dated  February  15, 2002 and  completed on
February 22, 2002, acquired 100% of the issued and outstanding shares of B2B, in
exchange for 2,600,000  (13,000,000 post forward split) restricted shares of the
Company.  B2B was  incorporated  in British  Columbia on  December  15, 2000 and
commenced operations on July 1, 2001.

During the fourth  quarter of 2002 the Company  ceased the operations of B2B due
to a lack of working capital and  accordingly,  at February 28, 2003,  wrote off
the carrying  value of the goodwill  relating to B2B of $41,075.  As part of the
conditions  of the  Company's  reverse  merger with Crown  Delaware  the Company
agreed to  dispose of its  investment  in B2B in return  for the  surrender  for
cancellation  of  13,000,000  Company  shares  issued  in  connection  with  the
acquisition of B2B which was completed on February 23, 2004. (Refer to Note 3.)

NOTE 7 - CAPITAL STOCK

The Company's  capitalization  is  70,000,000  common shares with a par value of
$0.001 per share and 5,000,000 preferred shares with a par value of $0.001.

During  the year  ended  February  28,  2003 the  Company  completed  a  private
placement of 290,367  (1,451,835  post forward  split)  common  shares for total
proceeds of $87,110.

On July 14,  2003,  the Company  completed a 5:1 stock split of its  outstanding
share  capital in connection  with the proposed  acquisition  of Crown  Delaware
resulting in an increase in outstanding  common shares from 6,390,367  shares to
31,951,835 shares.

Unless otherwise noted,  except in the Statement of  Stockholders'  Equity,  all
references to common stock, common shares outstanding, average numbers of common
shares outstanding and per share amounts in these Financial Statements and Notes
to Financial  Statements  prior to the effective date of the reverse stock split
have been  restated to reflect the five for one forward  split on a  retroactive
basis.

On January 28, 2004 the Company issued  1,500,000  common shares valued at $1.00
per  share  in  exchange  for the  acquisition  of the  rights  to MD  PaperFree
software.

On February 23, 2004, the Company acquired to treasury and cancelled  13,000,000
shares in connection with the disposal of B2B. (Refer to Note 6.)

To February 29, 2004,  the Company has not granted any stock options and has not
recorded any stock-based compensation.


                                       28
<PAGE>


NOTE 8 - INCOME TAXES

The Company has net operating  loss  carry-forwards  of  approximately  $50,000,
which may be available to offset future taxable income. These losses will expire
beginning in 2022.  Due to the  uncertainty  of  realization of these loss carry
forwards,  the  benefit is not  reflected  in the  financial  statements  as the
Company has  provided a full  valuation  allowance  for the  deferred tax assets
resulting from these loss carry forwards.

NOTE 9 - COMMITMENT

By  agreement  dated  January  12,  2004,  the Company  entered  into a one year
investor relations contract at $5,000 per month.

NOTE 10 - SUPPLEMENTAL DISCLOSURE WITH RESPECT TO CASH FLOWS

<TABLE>
<CAPTION>
================================= ============================ =================================
                                          Year ended                      Year ended
                                       February 29, 2004              February 28, 2003
--------------------------------- ---------------------------- ---------------------------------
<S>                                           <C>                             <C>
Cash paid during the year for:
           Interest                           $     -                         $       -
           Income taxes                       $     -                         $       -
================================= ============================ =================================
</TABLE>

During the year the Company issued  1,500,000  shares with a fair value of $1.00
per  share  in  exchange  for the  acquisition  of the  rights  to MD  PaperFree
software.

ITEM 8: CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE

None.


                                       29
<PAGE>

ITEM 8A.   CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures:

           Within  the 90 days  prior to the  filing  date of this  report,  the
           Company carried out an evaluation of the  effectiveness of the design
           and operation of its disclosure  controls and procedures  pursuant to
           Exchange  Act  Rule  13a-14.  This  evaluation  was  done  under  the
           supervision and with the participation of the Company's President and
           Chief Financial Officer.  Based upon that evaluation,  they concluded
           that the Company's  disclosure  controls and procedures are effective
           in gathering,  analyzing and disclosing information needed to satisfy
           the Company's disclosure obligations under the Exchange Act.

Changes in internal controls:
           There were no significant  changes in the Company's internal controls
           or in other factors that could  significantly  affect those  controls
           since the most recent evaluation of such controls.

PART III

ITEM 9: DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS

As of 29 February 2004,  the following are the directors and executive  officers
of the Company.

DIRECTORS:

Name of Director                          Age
----------------                          ---
Darlene Cox                               64
Brian Knight                              54
G. Paul Marshall                          41
William L. Sklar                          56
James Sterling                            57


EXECUTIVE OFFICERS:

<TABLE>
<CAPTION>
Name of Officer                Age        Office
--------------                 ---        ------
<S>                            <C>        <C>
William L Sklar                56         President, Chief Executive Officer
G. Paul Marshall               41         Secretary and Treasurer, Chief Financial Officer
</TABLE>

Set forth below is a brief description of the background and business experience
of each of our executive officers and directors for the past five years.

DARLENE  L.  COX,  Age 52,  is an  executive  healthcare  consultant,  providing
healthcare management and planning  consultation,  Cox was the president and CEO
of Essex Valley Healthcare Inc., East Orange General Hospital in New Jersey, for
three years. Previously, Cox was vice president and chief nursing officer at the
New York Presbyterian  Hospital for five years. Ms. Cox was appointed a Director
on February 17, 2004


                                       30
<PAGE>

BRIAN D.  KNIGHT,  age 54, has been  chief  executive  officer of Crown  Medical
Systems,  Inc  (Delaware)  since  February 2003; he served as its president from
July 2001 to April  2003 and its  executive  vice  president  from April 2002 to
February 2003.  Prior to joining Crown  (Delaware) in July 2001, since September
1998, Mr. Knight was a self-employed  consultant  involved with medical software
sales.  He has served as a director  since July 2001. Mr. Knight was appointed a
Director on January 17, 2004.

G. PAUL  MARSHALL,  age 41, has served as a director  of Crown  since  September
2003. He has been a self-employed  business  consultant since 1987. Mr. Marshall
was appointed a Director on January 17, 2004.

WILLIAM L SKLAR,  Age 56 Mr.  Sklar,  has been Director and President of Willmar
Management Corp., a consulting  company providing  management and administrative
advice and assistance to private and public companies in the United States,  the
United  Kingdom and Canada.  Mr.  Sklar was  appointed a Director on January 17,
2004.

JAMES A.  STERLING,  age 57, has been  executive vice president of Crown Medical
Systems,  Inc (Delaware) since February 2003. Mr. Sterling was Vice President of
Turney Systems  (information  processing) from July 2000 to April 2002 and sales
manager of W. Silver, Inc.  (recycling) from May 1998 to July 2000. Mr. Sterling
was appointed a Director on January 17, 2004.

FORMER PRESIDENT, SECRETARY AND DIRECTORS

EARL W. HOPE has  provided  consulting  services to St.  Elias Mines Ltd. in the
areas of finance,  investor and shareholder  relations since June 2000. Mr. Hope
has experience with private and public traded companies. He spent 29 years as an
Account Executive with several national and international  securities firms such
as Midland Walwyn Inc., West Coast  Securities  Ltd. and Canaccord  Capital Inc.
His duties and  responsibilities  in this capacity included:  customer services,
initial public  offerings and market  underwritings.  Mr. Hope has completed the
Canadian  Securities  Course,  the  Series 62 US  Corporate  Securities  Limited
Representative  License  and Series 63 Uniform  Securities  and Agent  State Law
Exam. Mr. Hope acts as a director of Infinex  Ventures,  Inc., a U.S.  reporting
company.  Mr.  Hope  resigned as  President  and as a Director of the Company on
January 17, 2004.

MARIO C.  AIELLO has 17 years  experience  as an advisor and  consultant  in the
corporate  and financial  markets.  In a consulting  capacity,  he has developed
financial   and   administrative   programs   for  clients  in  the   high-tech,
manufacturing  and  natural  resources  markets.  He has  been  responsible  for
financing many of these companies and for securing  trading status for more than
25 of them, both on U.S. and Canadian  exchanges.  For the past 10 years, he has
been President and Director of MCA Equities Ltd., a consulting company providing
management  and  administrative  advice and  assistance  to  private  and public
companies in both Canada and the United  States.  He has been active in business
development  in  various  regions  of China  for the last  three  years.  He was
responsible for evaluating different business opportunities and was instrumental
in negotiating a number of joint ventures for Chinese corporate entities.  Mario
Aiello  presently  acts as a director  Infinex  Ventures,  Inc.,  a US reporting
company, and Strategic Internet Investment Inc., a company whose shares trade on
the OTC  Bulletin  Board.  Mr.  Aiello  resigned as a Director of the Company on
January 17, 2004 and resigned as Secretary on March 1, 2004

ROBERT HOEGLER has been an investment consultant to public and private companies
for the past 20 years.  Mr. Hoegler is President of MCA Equities Ltd., a private
consulting  company that provides  advice to public  companies in Canada and the
United States.  He is also a director of Eiger  Technology Inc., a Toronto Stock
Exchange listed company that  manufactures  electronic  lighting  ballasts.  Mr.
Hoegler resigned as a Director on January 17, 2004

TERM OF OFFICE

Our  Directors  are  appointed for a one-year term to hold office until the next
annual  general  meeting of our  shareholders  or until  removed  from office in
accordance with our bylaws. Our officers are appointed by our board of directors
and hold office until removed by the board.


                                       31
<PAGE>

SIGNIFICANT EMPLOYEES

None

FAMILY RELATIONSHIPS

There  are  no  other  family  relationships  among  our  officers,   directors,
promoters, or persons nominated for such positions.

LEGAL PROCEEDINGS

No officer,  director,  or persons  nominated  for such  positions,  promoter or
significant  employee  has been  involved  in legal  proceedings  that  would be
material to an evaluation of our management.

Our directors,  executive officers and control persons have not been involved in
any of the following events during the past five years:

     1. any  bankruptcy  petition filed by or against any business of which such
person was a general  partner  or  executive  officer  either at the time of the
bankruptcy or within two years prior to that time;

     2. any  conviction  in a criminal  proceeding or being subject to a pending
criminal proceeding (excluding traffic violations and other minor offences);

     3. being  subject  to any order,  judgement,  or decree,  not  subsequently
reversed,  suspended  or  vacated,  of  any  court  of  competent  jurisdiction,
permanently or temporarily enjoining,  barring, suspending or otherwise limiting
his involvement in any type of business, securities or banking activities; or

     4. being found by a court of competent jurisdiction (in a civil action),the
Commission  or the  Commodity  Futures  Trading  Commission  to have  violated a
federal or state  securities or commodities  law, and the judgement has not been
reversed, suspended, or vacated.

COMMITTEES OF THE BOARD OF DIRECTORS

We presently do not have an audit committee,  compensation committee, nominating
committee,  an  executive  committee  of our  board  of  directors,  stock  plan
committee  or  any  other  committees.   However,  our  board  of  directors  is
considering establishing various such committees during the current fiscal year.
Currently,  our Board of Directors makes the decisions  regarding  compensation,
our  audit,  the  appointment  of  auditors,  and  the  inclusion  of  financial
statements in our periodic reports.

AUDIT COMMITTEE

We have no  financial  expert.  We believe  that the cost related to retaining a
financial expert at this time is prohibitive.

Identification of Audit Committee

The Company  does not have a  separately-designated  standing  audit  committee.
Rather,  Crown's  audit  committee  is  comprised  of all of its  directors  and
officers..  Crown's  audit  committee  is  responsible  for: (1)  selection  and
oversight of our independent  accountant;  (2)  establishing  procedures for the
receipt,  retention and treatment of complaints regarding  accounting,  internal
controls and auditing matters; (3) establishing procedures for the confidential,
anonymous  submission  by our  employees of concerns  regarding  accounting  and
auditing  matters;  (4)  engaging  outside  advisors;  and,  (5) funding for the
outside  auditory and any outside  advisors  engagement by the audit  committee.
Communicate has adopted an audit committee  charter, a copy of which is filed as
an exhibit to this report.


                                       32
<PAGE>

CODE OF ETHICS

We have not yet adopted a corporate  code of ethics.  Our board of  directors is
considering  establishing,  over  the  next  year,  a code of  ethics  to  deter
wrongdoing and promote honest and ethical conduct; provide full, fair, accurate,
timely and understandable  disclosure in public reports;  comply with applicable
laws;  ensure  prompt  internal  reporting  of  code  violations;   and  provide
accountability for adherence to the code.

ITEM 10: EXECUTIVE COMPENSATION

The table below  summarizes all  compensation  awarded to, earned by, or paid to
our executive officers by any person for all services rendered in all capacities
to us for the fiscal year ended February 29, 2004.

<TABLE>
<CAPTION>
                                                       Annual Compensation                        Long Term Compensation Awards
                                                       -------------------                        -------------------------------
Name & Position                     Year      Salary       Bonus        Other Compensation        Restricted Stock    Securities
                                                                                                  Awards              Underlying
                                                                                                                      Options/SAR
<S>                                 <C>       <C>          <C>          <C>                       <C>                 <C>
William  L. Sklar - President/      2004      0            0            0                         0                   0
Director
G. Paul Marshall - Secretary/CFO    2004      0            0            0                         0                   0
Darlene Cox Director                2004      0            0            0                         0                   0
Brian Knight Director               2004      0            0            0                         0                   0
James Sterling Director             2004      0            0            0                         0                   0
Earl Hope - Former President/       2004      0            0            0                         0                   0
former Director
                                    2003      0            0            0                         0                   0
Mario Aiello - Former CFO/ former   2004      0            0            1,000 Consulting fee      0                   0
Director
                                    2003      0            0            0                         0                   0
Robert Hoegler - Former Director    2004      0            0            0                         0                   0
                                    2003      0            0            0                         0                   0
</TABLE>


Section 16(A) Beneficial Ownership Reporting Compliance



                                       33
<PAGE>

Section 16(a) of the Exchange Act requires our executive officers and directors,
and persons who beneficially own more than 10% of our equity securities, to file
reports of ownership and changes in ownership  with the  Securities and Exchange
Commission.  Officers,  directors and greater than 10% shareholders are required
by SEC  regulation  to furnish us with  copies of all  Section  16(a) forms they
file.  Based on our review of the copies of such forms we  received,  we believe
that during the fiscal year ended October 31, 2002 all such filing  requirements
applicable to our officers and directors were complied with.

ITEM 11: SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information regarding the beneficial ownership of
our shares of common  stock at June 9, 2004 by (i) each person known by us to be
the beneficial owner of more than 5% of our outstanding  shares of common stock,
(ii)  each of our  directors,  (iii)  our  executive  officers,  and (iv) by all
directors and executive officers as a group. Each person named in the table, has
sole  voting  and  investment   power  with  respect  to  all  shares  shown  as
beneficially  owned by such person and can be contacted at our executive  office
address.

<TABLE>
<CAPTION>
                     Name and Address                     Amount and Nature       Percent
Title of Class       of Beneficial Owner                  of Beneficial Owner     of Class

<S>                  <C>                                  <C>                     <C>
Common Stock         Earl Hope (*)                        10,000,000              48.9%
                     639 Newport Street
                     Coquitlam, British Columbia
                     V3J 3H5

                     Mark & Sonja Jennings                 1,500,000               7.3%
                     2101 Jackson Lane
                     Anderson, IN
                     460114-9260

Common Stock         All current executive officers NIL                            0 %

                     And directors as a group
</TABLE>

The percent of class is based on  20,451,835  shares of common  stock issued and
outstanding as of June 9, 2004

(*) Mr. Hope has agreed to surrender all 10,000,000  Common Shares in connection
with the proposed merger with Crown Delaware.


                                       34
<PAGE>

ITEM 12: CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Except as disclosed below,  during our most recently completed fiscal year, none
of our  directors  or  officers,  nor any  proposed  nominee  for  election as a
director,  nor any person who beneficially owns, directly or indirectly,  shares
carrying more than 10% of the voting rights  attached to all of our  outstanding
shares,  nor any  promoter,  nor any relative or spouse of any of the  foregoing
persons has any material interest,  direct or indirect, in any transaction since
our  incorporation  or in any presently  proposed  transaction  which, in either
case, has or will materially affect us.

Our management is involved in other  business  activities and may, in the future
become  involved  in  other  business  opportunities.  If  a  specific  business
opportunity  becomes  available,  such  persons may face a conflict in selecting
between our business  and their other  business  interests.  In the event that a
conflict of interest  arises at a meeting of our  directors,  a director who has
such a conflict  will disclose his interest in a proposed  transaction  and will
abstain from voting for or against the approval of such transaction.

ITEM 13: EXHIBITS AND REPORTS

(b) Two reports on Form 8-K were filed during the last  quarter of 2004.  In the
first  report filed  January 22,  2004,  the  acquisition  of MD  PaperFree  was
reported..  In the second  report,  filed January 28, 2004, the amended terms of
the MD PaperFree acquisition were reported.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

Audit Fees

The  aggregate  fees  billed for the fiscal  year ended  February  29,  2004 for
professional  services rendered by the principal accountant for the audit of our
annual  financial  statements  included  in our Form  10-KSB  and  review of the
quarterly financial statements included in our Form 10-QSB for services that are
normally  provided by the accountant in connection with statutory and regulatory
filings for engagements for these fiscal periods were approximately, $9,800..

Audit-Related Fees

None.

Tax Fees

None.

All Other Fees

None.

Exhibits

99.1 Certification of Chief Executive Officer pursuant to Section 302 of the
     Sarbanes-Oxley Act of 2002

99.2 Certification of Chief Financial Officer pursuant to Section 302 of the
     Sarbanes-Oxley Act of 2002


                                       35
<PAGE>

SIGNATURES

Pursuant to the requirements of Section 13 and 15 (d) of the Securities Exchange
Act of 1934,  the  Registrant  has duly  caused  this report to be signed on its
behalf by the undersigned, thereunto duly authorized.


Crown Medical Systems, Inc (formerly Link Media Publishing Ltd.)

By

------------------------------------------------------------------------

           William L Sklar

           President, CEO & Director

           Date: June 11, 2004


In  accordance  with the  Securities  Exchange  Act, this report has been signed
below by the following persons on behalf of the registrant and in the capacities
and on the dates indicated.

By         /s/ William L Sklar

------------------------------------------------------------------------

           William L Sklar

           President, CEO & Director

           Date: June 11, 2004



By         /s/ G. Paul Marshall

------------------------------------------------------------------------

           Secretary, Treasurer and Director

           Date: June 11, 2004

By         /s/ Darlene Cox

------------------------------------------------------------------------

           Darlene Cox

           Director

           Date: June 11, 2004

------------------------------------------------------------------------


                                       36
<PAGE>

By         /s/ Brian Knight


------------------------------------------------------------------------

           Brian Knight

           Director

           Date: June 11, 2004

------------------------------------------------------------------------

By         /s/ James Sterling

------------------------------------------------------------------------

           James Sterling

           Director

           Date: June 11, 2004

------------------------------------------------------------------------


                                       37